PortfoliosLab logo
Aimei Health Technology Co., Ltd (AFJK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG013411171

IPO Date

Jan 22, 2024

Highlights

Market Cap

$68.32M

EPS (TTM)

$0.23

PE Ratio

48.52

Gross Profit (TTM)

-$200.00K

EBITDA (TTM)

-$1.02M

Year Range

$10.24 - $11.20

Short %

0.01%

Short Ratio

0.01

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aimei Health Technology Co., Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aimei Health Technology Co., Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading data...

S&P 500

Returns By Period

Aimei Health Technology Co., Ltd (AFJK) has returned 4.30% so far this year and 7.51% over the past 12 months.


AFJK

YTD
4.30%
1M
0.09%
6M
4.10%
1Y
7.51%
3Y*
N/A
5Y*
N/A
10Y*
N/A

^GSPC (Benchmark)

YTD
6.43%
1M
4.73%
6M
7.43%
1Y
11.48%
3Y*
17.91%
5Y*
14.47%
10Y*
11.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

The table below presents the monthly returns of AFJK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.

Based on daily data since Jan 2024, the average daily return (also called the expected return) is 0.03%, while the average monthly return is 0.50%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.47%1.86%0.43%0.30%0.95%0.13%0.09%4.30%
20240.30%-0.26%1.04%0.00%0.58%0.29%0.39%0.48%0.38%0.95%0.28%0.85%5.42%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 95, AFJK is among the top 5% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AFJK is 9595
Overall Rank
The Sharpe Ratio Rank of AFJK is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of AFJK is 9090
Sortino Ratio Rank
The Omega Ratio Rank of AFJK is 9797
Omega Ratio Rank
The Calmar Ratio Rank of AFJK is 9898
Calmar Ratio Rank
The Martin Ratio Rank of AFJK is 9898
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aimei Health Technology Co., Ltd (AFJK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Aimei Health Technology Co., Ltd Sharpe ratios as of Jul 14, 2025 (values are recalculated daily):

  • 1-Year: 1.74
  • All Time: 1.65

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Aimei Health Technology Co., Ltd compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


Aimei Health Technology Co., Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Aimei Health Technology Co., Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aimei Health Technology Co., Ltd was 1.66%, occurring on Jan 29, 2025. Recovery took 4 trading sessions.

The current Aimei Health Technology Co., Ltd drawdown is 0.36%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-1.66%Jan 29, 20251Jan 29, 20254Feb 4, 20255
-1.32%Jun 20, 20241Jun 20, 202455Sep 9, 202456
-1.29%Jan 14, 20259Jan 27, 20251Jan 28, 202510
-1.14%Nov 14, 202426Dec 20, 20246Dec 31, 202432
-0.9%Oct 21, 20241Oct 21, 202417Nov 13, 202418
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aimei Health Technology Co., Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Aimei Health Technology Co., Ltd, comparing actual results with analytics estimates.


0.030.040.050.060.070.08AprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2025FebruaryMarch
0.03
Actual
Estimate

Valuation

The Valuation section provides an overview of how Aimei Health Technology Co., Ltd is priced in the market compared to other companies in the Shell Companies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for AFJK, comparing it with other companies in the Shell Companies industry. Currently, AFJK has a P/E ratio of 48.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AFJK relative to other companies in the Shell Companies industry. Currently, AFJK has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AFJK in comparison with other companies in the Shell Companies industry. Currently, AFJK has a P/B value of 1.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items